Species-conserved reconfigurations of brain network topology induced by ketamine
- PMID: 27093068
- PMCID: PMC4872411
- DOI: 10.1038/tp.2016.53
Species-conserved reconfigurations of brain network topology induced by ketamine
Abstract
Species-conserved (intermediate) phenotypes that can be quantified and compared across species offer important advantages for translational research and drug discovery. Here, we investigate the utility of network science methods to assess the pharmacological alterations of the large-scale architecture of brain networks in rats and humans. In a double-blind, placebo-controlled, cross-over study in humans and a placebo-controlled two-group study in rats, we demonstrate that the application of ketamine leads to a topological reconfiguration of large-scale brain networks towards less-integrated and more-segregated information processing in both the species. As these alterations are opposed to those commonly observed in patients suffering from depression, they might indicate systems-level correlates of the antidepressant effect of ketamine.
Conflict of interest statement
AM-L received consultance fees from Astra Zeneca, Elsevier, F. Hoffmann-La Roche, Gerson Lehrman Group, Lund-beck foundation, Outcome Europe Sárl, Outcome Sciences, Roche Pharma, Servier International and Thieme Verlag, and lecture fees—including the travel fees—from Abbott, Astra Zeneca, Aula Médica Congresos, BASF, Groupo Ferrer International, Janssen-Cilag, Lilly Deutschland, LVR Klinikum Düsseldorf, Servier Deutschland, Otsuka Pharmaceuticals. AJS is an employee and shareholder of Eli Lilly. ES is a full-time employee of Servier. The remaining authors declare no conflict of interest.
Figures




Similar articles
-
Ketamine effects on brain function--simultaneous fMRI/EEG during a visual oddball task.Neuroimage. 2011 Sep 15;58(2):508-25. doi: 10.1016/j.neuroimage.2011.06.045. Epub 2011 Jun 29. Neuroimage. 2011. PMID: 21723949 Clinical Trial.
-
Ketamine-dependent neuronal activation in healthy volunteers.Brain Struct Funct. 2017 Apr;222(3):1533-1542. doi: 10.1007/s00429-016-1291-0. Epub 2016 Aug 30. Brain Struct Funct. 2017. PMID: 27578365 Clinical Trial.
-
Pilot dose-response trial of i.v. ketamine in treatment-resistant depression.World J Biol Psychiatry. 2014 Sep;15(7):579-84. doi: 10.3109/15622975.2014.922697. Epub 2014 Jun 9. World J Biol Psychiatry. 2014. PMID: 24910102 Clinical Trial.
-
Ketamine and pharmacological imaging: use of functional magnetic resonance imaging to evaluate mechanisms of action.Behav Pharmacol. 2017 Dec;28(8):610-622. doi: 10.1097/FBP.0000000000000354. Behav Pharmacol. 2017. PMID: 29049083 Free PMC article. Review.
-
Subanesthetic ketamine: how it alters physiology and behavior in humans.Aviat Space Environ Med. 2005 Jul;76(7 Suppl):C52-8. Aviat Space Environ Med. 2005. PMID: 16018330 Review.
Cited by
-
Brain Network Segregation and Glucose Energy Utilization: Relevance for Age-Related Differences in Cognitive Function.Cereb Cortex. 2020 Oct 1;30(11):5930-5942. doi: 10.1093/cercor/bhaa167. Cereb Cortex. 2020. PMID: 32564073 Free PMC article.
-
Connectomic Underpinnings of Working Memory Deficits in Schizophrenia: Evidence From a replication fMRI study.Schizophr Bull. 2020 Jul 8;46(4):916-926. doi: 10.1093/schbul/sbz137. Schizophr Bull. 2020. PMID: 32016430 Free PMC article.
-
From Maps to Multi-dimensional Network Mechanisms of Mental Disorders.Neuron. 2018 Jan 3;97(1):14-31. doi: 10.1016/j.neuron.2017.11.007. Neuron. 2018. PMID: 29301099 Free PMC article. Review.
-
A critical evaluation of validity and utility of translational imaging in pain and analgesia: Utilizing functional imaging to enhance the process.Neurosci Biobehav Rev. 2018 Jan;84:407-423. doi: 10.1016/j.neubiorev.2017.08.004. Epub 2017 Aug 12. Neurosci Biobehav Rev. 2018. PMID: 28807753 Free PMC article. Review.
-
TRIAC Treatment Improves Impaired Brain Network Function and White Matter Loss in Thyroid Hormone Transporter Mct8/Oatp1c1 Deficient Mice.Int J Mol Sci. 2022 Dec 8;23(24):15547. doi: 10.3390/ijms232415547. Int J Mol Sci. 2022. PMID: 36555189 Free PMC article.
References
-
- Anticevic A, Corlett PR, Cole MW, Savic A, Gancsos M, Tang Y et al. N-methyl-D-aspartate receptor antagonist effects on prefrontal cortical connectivity better model early than chronic schizophrenia. Biol Psychiatry 2015; 77: 569–580. - PubMed
-
- Berman RM, Cappiello A, Anand A, Oren DA, Heninger GR, Charney DS et al. Antidepressant effects of ketamine in depressed patients. Biol Psychiatry 2000; 47: 351–354. - PubMed
-
- Zarate CA Jr, Singh JB, Carlson PJ, Brutsche NE, Ameli R, Luckenbaugh DA et al. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry 2006; 63: 856–864. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials